CMPS COMPASS Pathways Plc American Depository Shares Loading...

Loading chart...
Top Calls
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All Content✓
Source feeds
Buzzberg's Top 50 ✓
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
08:21
May 18
u/ShaveMyPineapple Reddit r/ValueInvesting
Compass Pathways is developing psychedelic therapy for treatment-resistant depression. Commenter (MD/PhD) claims it may lead a paradigm shift. Small-cap biotech with a novel, high-potential pipeline; if FDA approval path clears, significant upside. A speculative early-stage biotech bet on a new treatment class; high risk/reward. Regulatory rejection, clinical trial failures, competitive landscape (e.g., MAPS), capital dilution.
CMPS 1ST
LOW
05:43
Apr 19
u/Buddah_Chillz420 Reddit r/wallstreetbets
Compass Pathways (CMPS) is listed as one of the author's holdings poised to benefit from accelerated psychedelic therapy approvals. The author's logic is that sector-wide positive news will lift all boats in the psychedelic biotech space. A generic long bet on the sector, tied to a vague political headline. CMPS has its own clinical trial risks. The post's catalyst is not specific to CMPS. Stock performance may not correlate with political news.
CMPS 1ST
MED
18:29
Mar 15
seedy19tron Biotech trader, L/S
The author provides a routine portfolio update detailing additions, reductions, and closures across various biotech stocks.
CMPS

About CMPS Analyst Coverage

Buzzberg tracks CMPS (COMPASS Pathways Plc American Depository Shares) across 3 sources. 2 bullish vs 0 bearish calls from 3 analysts. Sentiment: predominantly bullish (67%). 3 total trade ideas tracked.